Anti-Dengue potential, Molecular Docking Study of Some Chemical constituents in the leaves of Isatis tinctoria

Document Type : Research Article


1 Department of Pure and Applied Chemistry, Faculty of Science, University of Maiduguri, Borno State, Nigeria.

2 Department of Chemistry, Faculty of Physical Sciences, Ahmadu Bello University, Zaria, Kaduna State, Nigeria.

3 Chemistry, Physical sciences, ABU, Zaria, Nigeria.


Dengue infection is a major public health challenge in several parts of the world, especially the sub-tropical and tropical regions. The development of agents that are able to inhibit the dengue virus (DNV) replication are therefore of utmost significance. I. tinctoria is one of the most investigated Chinese herbs, which has been recognised to be effective in the treatment of dengue fever. However, the mechanisms through which it exhibits such biological activity of great importance are still unclear. A total number of about 27 compounds isolated from I. tinctoria leaves which have been identified and reported in the literature to be effective against dengue fever were investigated for their inhibitory potencies against dengue virus as novel drugs for treating early attacks of dengue fever. The compounds were optimized by employing a method of Density functional theory (DFT) and a basis set of B3LYP (6-31G**). The results of Molecular docking investigation between the compounds and the dengue viral protein (PDB: 6MO1) revealed that three of the compounds (GB-20, GB-19, and GB-6) possessing best binding energy in of -27.051, -26.193 and -24.664 kcal/mol respective were observed to inhibit the target through hydrogen bonds and hydrophobic interactions with amino acids residue of the protease binding site. The results of these studies would offer relevant insight into structural requirements for the development of effective and a specific therapeutic treatment against dengue virus infection.


[1] S. S. Swain and D. Dude, Anti-dengue medicinal plants: a mini review. Res. Rev. J Pharmacogn Phytochem., 1 (2013) 5-9.
[2] M. E. Beatty, A. Stone, W. D. Fitzsimons, J. N. Hanna, S. K. Lam and S. Vong, Best practices in dengue surveillance: a report from the Asia-Pacific and Americas Dengue Prevention Boards. PLoS. Negl. Trop. Dis., 4 (2010) 890.
[3] Z. Fatima, M. Idrees, M. A. Bajwa, Z. Tahir, O. Ullah and M.Q. Zia, Serotype and genotype analysis of dengue virus by sequencing followed by phylogenetic analysis using samples from three mini outbreaks-2007-2009 in Pakistan. BMC Microbiol., 11 (2011)200.
[4] J. A. Ayukekbong, O. G. Oyero, S. E. Nnukwu, H. N. Mesumbe and C.N. Fobisong, Value of routine dengue diagnosis in endemic countries. World. J. Virol., 6 (2017) 9-16.
[5] C. Nitsche, S. Holloway, T. Schirmeister and C. D. Klein, Biochemistry and medicinal chemistry of the dengue virus protease. Chem Rev., 114 (2014) 11348–11381.
[6] A. J. Stevens, M. E. Gahan, S. Mahalingam and P. A. Keller, The medicinal chemistry of dengue fever. J. Med. Chem., 52 (2009) 7911–7926.
[7] S. P. Lim, Q. Y. Wang, C. G. Noble, Y. L. Chen, H. Dong, B. Zou, F. Yokokawa, S. Nilar, P. Smith, D. Beer, J. Lescar and P. Y. Shi, Ten years of dengue drug discovery: Progress and prospects. Antiviral Res., 100 (2013) 500–519.
[8] A. E. Sahili and J. Lescar, Dengue Virus Non-Structural Protein 5. Viruses., 9 (2017) 9.
[9] J. Lei, G. Hansen, C. Nitsche, C. D. Klein, L. Zhang and R. Hilgenfeld. The Crystal structure of Zika virus NS2B-NS3 protease in complex with a boronate inhibitor. Sci., 353 (2016) 503−505.
[10] C. Nitsche, L. Zhang, L. F. Weigel, J. Schilz, D. Graf, R. Bartenschlager, R. Hilgenfeld and C. D. Klein, Peptide–boronic acid inhibitors of flaviviral proteases: Medicinal chemistry and structural biology. J. Med. Chem., 60 (2017) 511−516.
[11] J. Suganya and R. Mahendran. Molecular docking studies of selected medicinal plant compounds against NS5 and NS3 protein of dengue virus: a comparative approach. Int. J. Pharm. Bio. Sci., 7 (2016) 1135 – 1144.
[12] Y. Yao, T. Huo, Y. Lin, S. Nie, F. Wu, Y. Hua, J. Wu, A. R. Kneubehl, M. B. Vogt, R. Rico-Hesse and Y. Song,
Discovery, X-ray crystallography and antiviral activity of allosteric inhibitors of flavivirus NS2B-NS3 protease. J. Am. Chem. Soc., 141 (2019) 6832-36.
[13] W. Schul, W. Liu, H. Y. Xu, M. Flamand and S. G. Vasudevan, A dengue fever viremia model in mice show a reduction in viral replication and suppression of the inflammatory response after treatment with antiviral drugs. J. Infect. Dis.,195 (2007) 665-674.
[14] W. J. Kassler, P. Blanc and R. Greenblatt, The use of medicinal herbs by human immunodeficiency virus-infected patients. Arch. Intern. Med., 151 (1991) 2281-2288.
[15] H. C. Ko, B. L. Wei and W. F. Chiou, The effect of medicinal plants used in Chinese folk medicine on RANTES secretion by virus-infected human epithelial cells. J. Ethnopharmacol., 107, (2006) 205-210.
[16] L. T. Lin, W. C. Hsu and C. C. Lin, Antiviral natural products and herbal medicines. J. Tradit. Complement. Med., 4 (2014) 24-35.
[17] S. L. Woodward and J. A. Quinn, Encyclopedia of Invasive Species: From Africanized Honey Bees to Zebra Mussels, Greenwood Publishing Group, Santa Barbara, CA, USA, 1. 2011.
[18] B. Gao, J. Zhang and L. Xie, Structure analysis of effective chemical compounds against dengue viruses isolated from I. tinctoria. Can. J. Infect. Dis. Med. Microbiol., 2018
[19] W. J. Hehre and W. W. Huang, Chemistry with Computation: An introduction to SPARTAN, Wavefunction, Inc; 1995.
[20] Z. Li, H. Wan, Y. Shi and P. Ouyang, Personal experience with four kinds of chemical structure drawing software: a review on ChemDraw, ChemWindow, ISIS/Draw, and ChemSketch. J. Chem. Inform. Comput. Sci., 44 (2004) 1886-1890.
[21] E. R. Davidson and D. Feller, Basis set selection for molecular calculations. Chem. Rev., 86 (1986) 681-696.
[22] A. Schäfer, H. Horn and R. Aldrichs, Fully optimized contracted Gaussian basis sets atoms Li to Kr. The Journal of Chemical Physics, 97 (1992) 2571-2577.
[23] A. El Sahili, T. S. Soh, J. Schiltz, A. Gharbi-Ayachi, C. C. She, P. Y. Shi and J. Lescar, NS5 from dengue virus serotype 2 can adopt a conformation analogous to that of its zika virus and Japanese encephalitis virus homologues. J. Virol., 94 (2019) e01294-19.
[24] M. A. Neves, M. Totrov and R. Abagyan, Docking and scoring with ICM: the benchmarking results and strategies for improvement. J. Comput. Aided Mol. Des., 26 (2012) 675-86.
[25] J. Joubert, E. B. Foxen and S. F. Malan, Microwave optimized synthesis of N-(adamantan-1-yl)-4-[(adamantan-1-yl)-sulfamoyl] benzamide and its derivatives for anti-dengue virus activity. Molecules., 23 (2018) 1678.
[26] K. Zandi, R. Lani, P. E. Wong, B. T. Teoh, S. S. Sam, J. Johari, M. R. Mustafa, S. Abubakar, Flavone enhances dengue virus type-2 (NGC strain) infectivity and replication in Vero cells. Molecules., 17 (2012) 2437-2445.
[27] K. Zandi, B. T. Teoh, S. S. Sam, P. F. Wong, M. R. Mustafa, S. Abubakar, Novel antiviral activity of baicalein against dengue virus. BMC. Complement. Altern. Med., 12 (2012) 214.
[28] Ahn HC, Lee SY, Kim JW, Son WS, Shin CG, Lee BJ. Binding aspects of baicalein to HIV-1 intergrase. Mol. Cells., 12 (2001) 127-130.